These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 18633975)

  • 1. Investigational methods for peroxisomal disorders.
    Steinberg S; Jones R; Tiffany C; Moser A
    Curr Protoc Hum Genet; 2008 Jul; Chapter 17():Unit 17.6. PubMed ID: 18633975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperpipecolic acidaemia: a diagnostic tool for peroxisomal disorders.
    Peduto A; Baumgartner MR; Verhoeven NM; Rabier D; Spada M; Nassogne MC; Poll-The BT; Bonetti G; Jakobs C; Saudubray JM
    Mol Genet Metab; 2004 Jul; 82(3):224-30. PubMed ID: 15234336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gas chromatography/mass spectrometry analysis of very long chain fatty acids, docosahexaenoic acid, phytanic acid and plasmalogen for the screening of peroxisomal disorders.
    Takemoto Y; Suzuki Y; Horibe R; Shimozawa N; Wanders RJ; Kondo N
    Brain Dev; 2003 Oct; 25(7):481-7. PubMed ID: 13129591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic diseases caused by peroxisomal dysfunction. New findings in clinical and biochemical studies.
    Schutgens RB; Wanders RJ; Nijenhuis A; van den Hoek CM; Heymans HS; Schrakamp G; Bleeker-Wagemakers EM; Delleman JW; Schram AW; Tager JM
    Enzyme; 1987; 38(1-4):161-76. PubMed ID: 3440444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peroxisome biogenesis disorders.
    Steinberg SJ; Dodt G; Raymond GV; Braverman NE; Moser AB; Moser HW
    Biochim Biophys Acta; 2006 Dec; 1763(12):1733-48. PubMed ID: 17055079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of very long-chain fatty acids and plasmalogen in the erythrocyte membrane: a simple method for the detection of peroxisomal disorders and discrimination between adrenoleukodystrophy and Zellweger syndrome.
    Tanaka K; Nishizawa K; Yamamoto H; Naruto T; Izeki E; Taga T; Shimada M; Saeki Y
    Neuropediatrics; 1990 Aug; 21(3):119-23. PubMed ID: 2234315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of machine learning algorithms for the differential diagnosis of peroxisomal disorders.
    Subhashini P; Jaya Krishna S; Usha Rani G; Sushma Chander N; Maheshwar Reddy G; Naushad SM
    J Biochem; 2019 Jan; 165(1):67-73. PubMed ID: 30295825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human disorders of peroxisome metabolism and biogenesis.
    Waterham HR; Ferdinandusse S; Wanders RJ
    Biochim Biophys Acta; 2016 May; 1863(5):922-33. PubMed ID: 26611709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The diagnosis of peroxisomal disorders in Spain during the period 1987-1997].
    Girós M; Ruiz M; Ribes A; Pàmpols T
    Rev Neurol; 1999 Jan; 28 Suppl 1():S40-4. PubMed ID: 10778487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and Biochemical Pitfalls in the Diagnosis of Peroxisomal Disorders.
    Klouwer FC; Huffnagel IC; Ferdinandusse S; Waterham HR; Wanders RJ; Engelen M; Poll-The BT
    Neuropediatrics; 2016 Aug; 47(4):205-20. PubMed ID: 27089543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum very-long-chain fatty acids levels determined by gas chromatography in the diagnosis of peroxisomal disorders in Poland.
    Stradomska TJ; Tylki-Szymańska A
    Folia Neuropathol; 2009; 47(4):306-13. PubMed ID: 20054782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Peroxisomal diseases--a survey].
    Theron JJ; van Papendorp DH
    S Afr Med J; 1996 Jun; 86(6):685-90. PubMed ID: 8764428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and diagnostic value of phytanoyl- and pristanoyl-carnitine in plasma from patients with peroxisomal disorders.
    Herzog K; van Lenthe H; Wanders RJA; Vaz FM; Waterham HR; Ferdinandusse S
    Mol Genet Metab; 2017 Jul; 121(3):279-282. PubMed ID: 28566232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasmalogens participate in very-long-chain fatty acid-induced pathology.
    Brites P; Mooyer PA; El Mrabet L; Waterham HR; Wanders RJ
    Brain; 2009 Feb; 132(Pt 2):482-92. PubMed ID: 19022859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pseudo infantile Refsum's disease: catalase-deficient peroxisomal particles with partial deficiency of plasmalogen synthesis and oxidation of fatty acids.
    Aubourg P; Kremser K; Roland MO; Rocchiccioli F; Singh I
    Pediatr Res; 1993 Sep; 34(3):270-6. PubMed ID: 7510868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Peroxisomal disorders].
    Stradomska TJ
    Postepy Biochem; 2018 Dec; 64(4):359-367. PubMed ID: 30656921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristic acylcarnitine profiles in inherited defects of peroxisome biogenesis: a novel tool for screening diagnosis using tandem mass spectrometry.
    Rizzo C; Boenzi S; Wanders RJ; Duran M; Caruso U; Dionisi-Vici C
    Pediatr Res; 2003 Jun; 53(6):1013-8. PubMed ID: 12646728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical markers predicting survival in peroxisome biogenesis disorders.
    Gootjes J; Mooijer PA; Dekker C; Barth PG; Poll-The BT; Waterham HR; Wanders RJ
    Neurology; 2002 Dec; 59(11):1746-9. PubMed ID: 12473763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Peroxisomal hereditary metabolic disorders].
    Chandoga J; Petrovic R
    Cas Lek Cesk; 2001 Oct; 140(21):651-7. PubMed ID: 11766453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pre- and postnatal diagnosis of peroxisomal disorders using stable-isotope dilution gas chromatography--mass spectrometry.
    Verhoeven NM; Kulik W; van den Heuvel CM; Jakobs C
    J Inherit Metab Dis; 1995; 18 Suppl 1():45-60. PubMed ID: 9053555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.